Skip to main content

News Archive

News Archive - School of Medicine

Identified Genetic Interaction Offers Possible New Target for Glaucoma Therapy

September 10, 2015

Scientists at the University of California, San Diego School of Medicine have elucidated a genetic interaction that may prove key to the development and progression of glaucoma, a blinding neurodegenerative disease that affects tens of millions of people worldwide and is a leading cause of irreversible blindness.

San Diego Events Map Future of Brain Research and Remedies

September 8, 2015

Two University of California, San Diego-sponsored events in September, over two consecutive Saturdays, highlight the importance of a comprehensive approach to brain research. First, on Sept. 12, is an education and advocacy forum for the public bringing together those affected by Alzheimer's disease, Parkinson's disease, brain injury, stroke, epilepsy, autism, mental illness or depression. Then on Sept. 19 a research symposium will connect local “neurotechnology” innovators to one another and to the region’s business community.

Stem Cell-derived “Mini-brains” Reveal Potential Drug Treatment for Rare Disorder

September 8, 2015

Using “mini-brains” built with induced pluripotent stem cells derived from patients with a rare, but devastating, neurological disorder, researchers at University of California, San Diego School of Medicine say they have identified a drug candidate that appears to “rescue” dysfunctional cells by suppressing a critical genetic alteration.

Rapid Testing for TB Aims to Reduce Drug Resistance, Lower Mortality Rate

September 3, 2015

Researchers at University of California, San Diego School of Medicine have documented the accuracy of three new tests for more rapidly diagnosing drug-resistant forms of tuberculosis (TB), which are much harder and more expensive to treat and which, experts say, represent a major threat to global public health.

Targeting Newly Discovered Pathway Sensitizes Tumors to Radiation and Chemotherapy

September 3, 2015

In some patients, aggressive cancers can become resistant to chemotherapy and radiation treatments. In a paper published in the journal Nature Communications, University of California, San Diego School of Medicine researchers identified a pathway that causes the resistance and a new therapeutic drug that targets this pathway.

UC San Diego Health to Manage Emergency Services at El Centro Regional Medical Center

September 2, 2015

From comprehensive stroke care when every second counts to stitching deep cuts and evaluating flu symptoms, UC San Diego Health provides the highest quality of care when patients arrive through the emergency room doors. Now, as part of a long term partnership between UC San Diego Health and El Centro Regional Medical Center (ECRMC), patients in the Imperial Valley will receive the same specialty emergency care.

UC San Diego Scientists Investigate Global Hemorrhagic Fever Bacterial Disease

September 1, 2015

An international research team, headed by Joseph Vinetz, MD, professor of medicine at University of California, San Diego School of Medicine and director of the UC San Diego Center for Tropical Medicine and Travelers Health, has been awarded a 5-year, $1.89 million cooperative agreement to carry out translational research studies of leptospirosis, an infectious and sometimes fatal bacterial disease endemic in much of the world.

UC San Diego Cancer Researchers Receive NCI Outstanding Investigator Award

August 28, 2015

Four University of California, San Diego School of Medicine researchers have been selected to receive the newly established National Cancer Institute (NCI) Outstanding Investigator Award. The multi-million dollar awards fund new projects that have an unusual potential in cancer research over seven years.

Degenerating Neurons Respond to Gene Therapy Treatment for Alzheimer’s Disease

August 27, 2015

Degenerating neurons in patients with Alzheimer’s disease (AD) measurably responded to an experimental gene therapy in which nerve growth factor (NGF) was injected into their brains, report researchers at University of California, San Diego School of Medicine in the current issue of JAMA Neurology.

UC San Diego Health Announces Interim CEO

August 24, 2015

Patty Maysent, MPH, MBA, has been appointed interim Chief Executive Officer of UC San Diego Health, bringing to the role more than 25 years of exceptional executive experience in hospital leadership and health services management.
Category navigation with Social links